Similarly, Haukeland et al. showed no difference in the effects of metformin vs. placebo on histologic evidence of steatosis or steatohepatitis in 48 adults with NAFLD treated for 24 weeks, nor did they demonstrate differential effects on ALT reduction (28). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.